Shiraz E-Medical Journal

Published by: Kowsar

Impact of HBV Vaccination on Prevalence of Hepatitis B Virus Infection Among Volunteer Blood Donors in Tehran-Iran

Seyed Mohammad Mirrezaie 1 , 2 , Hamid Reza Saber 1 , 2 , Bashir Hajibeigi 1 , 2 , Ebadollah Salekmoghaddam 1 , 2 , Ali Abbasian 1 , 2 and Seyed Moayed Alavian 3 , 4 , *
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
2 Tehran Regional Educational Blood Transfusion Center, Tehran, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Middle East Liver Disease Center, Tehran, IR Iran
Article information
  • Shiraz E-Medical Journal: April 01, 2014, 15 (2); e18066
  • Published Online: April 20, 2014
  • Article Type: Research Article
  • Received: February 6, 2014
  • Accepted: March 13, 2014
  • DOI: 10.17795/semj18066

To Cite: Mirrezaie S M, Saber H R, Hajibeigi B, Salekmoghaddam E, Abbasian A, et al. Impact of HBV Vaccination on Prevalence of Hepatitis B Virus Infection Among Volunteer Blood Donors in Tehran-Iran, Shiraz E-Med J. 2014 ; 15(2):e18066. doi: 10.17795/semj18066.

Abstract
Copyright © 2014, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 2. Alavian SM, Lankarani KB. Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children. J Compr Ped. 2012; 3(1): 1-2
  • 3. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007; 7(1): 3-5
  • 4. de Paula Machado DF, Martins T, Trevisol DJ, Vieira ESRA, Narciso-Schiavon JL, Schuelter Trevisol F, et al. Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern brazilian city. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 5. Adibi P. Why we still need HBV population-based epidemiologic studies. Hepat Mon. 2012; 12(2): 71-2[DOI][PubMed]
  • 6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002; 2(7): 395-403[PubMed]
  • 7. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 8. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 9. Alavian SM, Tabatabaei SV, Nourizad S, Mansouri F, Khademi N, Kafi-abad SA, et al. Seroepidemiology of HBV Infection in Kermanshah-West of Iran; A Population Based Study. Jundishapur JMicrobiol. 2012; 5(4)
  • 10. Campagna M, Siddu A, Meloni A, Basciu C, Ferrai L, Pettinau A, et al. Changing pattern of hepatitis a virus epidemiology in an area of high endemicity. Hepat Mon. 2012; 12(6): 382-5[DOI][PubMed]
  • 11. Van Herck K, Van Damme P. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J. 2008; 27(10): 861-9[DOI][PubMed]
  • 12. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2): 62-7[PubMed]
  • 13. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006; 36(4): 265-71[DOI][PubMed]
  • 14. Alam Mehrjerdi Z, Noroozi A. An emerging trend of methamphetamine injection in iran: a critical target for research on blood-borne infection diseases. Hepat Mon. 2013; 13(2)[DOI][PubMed]
  • 15. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, et al. Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon. 2012; 12(7): 442-7[DOI][PubMed]
  • 16. Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinzadeh AM, Haghazali M, et al. Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage Using Administrative Data. Hepat Mon. 2009; 9(3)
  • 17. Yoshikawa A, Suzuki K, Abe A, Tanaka T, Yamaguchi K, Tanaka T, et al. Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors. Transfus Med. 2009; 19(4): 172-9[DOI][PubMed]
  • 18. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4)
  • 19. Mackie CO, Buxton JA, Tadwalkar S, Patrick DM. Hepatitis B immunization strategies: timing is everything. CMAJ. 2009; 180(2): 196-202[DOI][PubMed]
  • 20. Sakarya S, Oncu S, Ozturk B, Oncu S. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey. Saudi Med J. 2004; 25(8): 1070-2[PubMed]
  • 21. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010; 202(2): 192-201[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments